Mepolizumab or Placebo for Eosinophilic Granulomatosis with Polyangiitis

May 23, 2017- interviewed by Steven E. Greer, MD

We interviewed polumonologist Michael Wechsler, MD about his paper in the NEJM testing mepolizumab for the rare disease of Mepolizumab or Placebo for Eosinophilic
Granulomatosis with Polyangiitis